MicroRNA-494 represses osteosarcoma development by modulating ASK-1 related apoptosis complexes

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNA-494 (miR-494) involvement in tumor pathogenesis is known, but its role in osteosarcoma (OS) requires further investigation.
• Limited studies exist on miR-494's specific functions and expression patterns in OS development.

Purpose of the Study:

• To elucidate the expression profile of miR-494 in osteosarcoma.
• To investigate the functional roles of miR-494 in OS progression and development.
• To assess the prognostic significance of miR-494 in OS patients.

Main Methods:

• Utilized mouse models and osteoblastic cell lines to study miR-494 functions.
• Conducted a case-control study with 87 OS patients and 100 controls.
• Analyzed miR-494 expression in tumor and serum samples, correlating with clinical parameters and survival outcomes.

Main Results:

• miR-494 was significantly down-regulated in OS tissues and serum compared to controls, with levels positively associated between tissue and serum.
• Overexpression of miR-494 suppressed OS tumor growth and induced apoptosis, while its depletion promoted cell invasion.
• Low miR-494 expression correlated with advanced T stage, lymph node metastasis, and distant metastasis, predicting poorer overall survival.
• miR-494 modulates the ASK-1/STRAP/14-3-3 complex to promote TNF-α/ASK-1-mediated apoptosis.

Conclusions:

• miR-494 functions as a tumor suppressor in osteosarcoma.
• miR-494 significantly improves the prognosis of OS patients by regulating apoptosis.
• miR-494 represents a potential biomarker and therapeutic target for osteosarcoma.